Aytu Biopharma (AYTU) Revenue (2013 - 2026)
Aytu Biopharma (AYTU) posted quarterly Revenue of $12.4 million for Q1 2026, down 32.74% year-over-year from $18.5 million in Q1 2025, and down 18.16% quarter-over-quarter from $15.2 million in Q4 2025.
Aytu Biopharma (AYTU) Revenue (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Revenue for 14 consecutive years, with $12.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 32.74% year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $56.6 million (down 14.04% YoY), while the FY2025 annual figure was $66.4 million, up 1.84% from the prior year.
- Revenue declined to $12.4 million in Q1 2026 per AYTU's latest filing, from $15.2 million in the prior quarter.
- Across five years, Revenue topped out at $30.7 million in Q2 2023 and bottomed at $12.4 million in Q1 2026.
- Historically, Revenue has averaged $19.5 million across 5 years, with a median of $17.8 million in 2023.
- Annual changes were most pronounced in 2024 — Revenue sank 52.52% — and 2025, when it jumped 31.57%.
- Aytu Biopharma's Revenue stood at $26.3 million in 2022, then declined by 28.66% to $18.7 million in 2023, then fell by 13.48% to $16.2 million in 2024, then fell by 6.51% to $15.2 million in 2025, then retreated by 18.16% to $12.4 million in 2026.
- Business Quant data shows AYTU's Revenue at $12.4 million in Q1 2026, $15.2 million in Q4 2025, and $13.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn | 12.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.41 Mn |
| Dec 31, 2025 | 15.17 Mn |
| Sep 30, 2025 | 13.89 Mn |
| Jun 30, 2025 | 15.14 Mn |
| Mar 31, 2025 | 18.45 Mn |
| Dec 31, 2024 | 16.22 Mn |
| Sep 30, 2024 | 16.57 Mn |
| Jun 30, 2024 | 14.59 Mn |
| Mar 31, 2024 | 14.03 Mn |
| Dec 31, 2023 | 18.75 Mn |
| Sep 30, 2023 | 17.82 Mn |
| Jun 30, 2023 | 30.73 Mn |
| Mar 31, 2023 | 22.73 Mn |
| Dec 31, 2022 | 26.28 Mn |
| Sep 30, 2022 | 27.66 Mn |
| Jun 30, 2022 | 27.45 Mn |
| Mar 31, 2022 | 24.20 Mn |
| Dec 31, 2021 | 23.13 Mn |
| Sep 30, 2021 | 21.90 Mn |
| Jun 30, 2021 | 23.48 Mn |